PL3313853T3 - Sposób syntezy pochodnych rapamycyny - Google Patents
Sposób syntezy pochodnych rapamycynyInfo
- Publication number
- PL3313853T3 PL3313853T3 PL16731862T PL16731862T PL3313853T3 PL 3313853 T3 PL3313853 T3 PL 3313853T3 PL 16731862 T PL16731862 T PL 16731862T PL 16731862 T PL16731862 T PL 16731862T PL 3313853 T3 PL3313853 T3 PL 3313853T3
- Authority
- PL
- Poland
- Prior art keywords
- synthesis
- rapamycin derivatives
- rapamycin
- derivatives
- Prior art date
Links
- 230000015572 biosynthetic process Effects 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- QFJCIRLUMZQUOT-HPLJOQBZSA-N sirolimus Chemical class C1C[C@@H](O)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 QFJCIRLUMZQUOT-HPLJOQBZSA-N 0.000 title 1
- 238000003786 synthesis reaction Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/16—Peri-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/18—Bridged systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15173283.1A EP3109250A1 (en) | 2015-06-23 | 2015-06-23 | Method for the synthesis of rapamycin derivatives |
| PCT/EP2016/064389 WO2016207205A1 (en) | 2015-06-23 | 2016-06-22 | Method for the synthesis of rapamycin derivatives |
| EP16731862.5A EP3313853B1 (en) | 2015-06-23 | 2016-06-22 | Method for the synthesis of rapamycin derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3313853T3 true PL3313853T3 (pl) | 2020-01-31 |
Family
ID=53488213
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL16731862T PL3313853T3 (pl) | 2015-06-23 | 2016-06-22 | Sposób syntezy pochodnych rapamycyny |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US10308665B2 (pl) |
| EP (2) | EP3109250A1 (pl) |
| JP (1) | JP6745823B2 (pl) |
| KR (1) | KR102621941B1 (pl) |
| CN (1) | CN107735398B (pl) |
| AR (1) | AR105091A1 (pl) |
| AU (1) | AU2016282816A1 (pl) |
| ES (1) | ES2741013T3 (pl) |
| HU (1) | HUE045651T2 (pl) |
| MX (1) | MX2017017022A (pl) |
| PL (1) | PL3313853T3 (pl) |
| RU (1) | RU2718058C2 (pl) |
| SI (1) | SI3313853T1 (pl) |
| TW (1) | TWI646100B (pl) |
| UY (1) | UY36746A (pl) |
| WO (1) | WO2016207205A1 (pl) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102641816B1 (ko) | 2016-07-19 | 2024-02-29 | 삼성디스플레이 주식회사 | 디스플레이 장치 |
| CN109206441B (zh) * | 2017-06-30 | 2022-05-20 | 正大天晴药业集团股份有限公司 | 一种依维莫司的纯化方法 |
| AR112834A1 (es) | 2017-09-26 | 2019-12-18 | Novartis Ag | Derivados de rapamicina |
| HRP20250197T1 (hr) | 2018-12-18 | 2025-04-11 | Novartis Ag | Derivati rapamicina |
| CN109776571B (zh) * | 2019-01-31 | 2021-06-11 | 哈药慈航制药股份有限公司 | 一种雷帕霉素类似物及其制备方法和应用 |
| RU2716714C1 (ru) * | 2019-08-26 | 2020-03-16 | Закрытое Акционерное Общество "Биокад" | Новый способ получения эверолимуса |
| CN113735880B (zh) * | 2020-05-29 | 2023-12-22 | 鲁南制药集团股份有限公司 | 一种依维莫司的制备方法及其中间体 |
| CN114671891A (zh) * | 2020-12-24 | 2022-06-28 | 鲁南制药集团股份有限公司 | 一种依维莫司乙基化杂质的制备方法 |
| CN115028658A (zh) * | 2022-07-06 | 2022-09-09 | 国药集团川抗制药有限公司 | 雷帕霉素硅醇酯及其制备方法和应用 |
| GB202415232D0 (en) | 2024-10-16 | 2024-11-27 | Nacamed As | Composition |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9221220D0 (en) | 1992-10-09 | 1992-11-25 | Sandoz Ag | Organic componds |
| GB0601406D0 (en) * | 2006-01-24 | 2006-03-08 | Novartis Ag | Organic Compounds |
| GB0609962D0 (en) * | 2006-05-19 | 2006-06-28 | Biotica Tech Ltd | Novel compounds |
| CN102127092B (zh) * | 2010-01-18 | 2013-04-17 | 东南大学 | 依维莫斯的制备 |
| ES2753529T3 (es) | 2010-11-19 | 2020-04-13 | Biocon Ltd | Procesos para la preparación de everolimús y productos intermedios del mismo |
| EP2670758B1 (en) * | 2011-02-04 | 2022-09-28 | Synthon BV | Process for making trisubstituted silyloxyethyl triflates |
| CN102268015B (zh) | 2011-08-30 | 2013-08-28 | 成都摩尔生物医药有限公司 | 一种依维莫司的合成方法 |
| CN102786534A (zh) | 2012-05-25 | 2012-11-21 | 上海现代制药股份有限公司 | 一种依维莫司的制备方法 |
| SG11201404432QA (en) * | 2012-11-30 | 2014-10-30 | Hangzhou Zylox Pharma Co Ltd | Rafamycin analogs and methods for making same |
| WO2014203185A1 (en) | 2013-06-20 | 2014-12-24 | Novartis Ag | Alkylation with an alkyl fluoroalkyl sulfonate |
| CN103848849B (zh) * | 2014-03-24 | 2016-02-24 | 上海医药工业研究院 | 依维莫司的制备工艺 |
| CN104478898A (zh) * | 2014-11-18 | 2015-04-01 | 连云港恒运医药科技有限公司 | 依维莫司及其中间体的制备方法 |
-
2015
- 2015-06-23 EP EP15173283.1A patent/EP3109250A1/en not_active Withdrawn
-
2016
- 2016-06-22 CN CN201680036479.1A patent/CN107735398B/zh active Active
- 2016-06-22 JP JP2017566621A patent/JP6745823B2/ja active Active
- 2016-06-22 AU AU2016282816A patent/AU2016282816A1/en not_active Abandoned
- 2016-06-22 WO PCT/EP2016/064389 patent/WO2016207205A1/en not_active Ceased
- 2016-06-22 ES ES16731862T patent/ES2741013T3/es active Active
- 2016-06-22 KR KR1020187001488A patent/KR102621941B1/ko active Active
- 2016-06-22 MX MX2017017022A patent/MX2017017022A/es unknown
- 2016-06-22 UY UY0001036746A patent/UY36746A/es not_active Application Discontinuation
- 2016-06-22 AR ARP160101863A patent/AR105091A1/es unknown
- 2016-06-22 SI SI201630337T patent/SI3313853T1/sl unknown
- 2016-06-22 RU RU2017144050A patent/RU2718058C2/ru active
- 2016-06-22 US US15/737,861 patent/US10308665B2/en active Active
- 2016-06-22 TW TW105119625A patent/TWI646100B/zh active
- 2016-06-22 PL PL16731862T patent/PL3313853T3/pl unknown
- 2016-06-22 EP EP16731862.5A patent/EP3313853B1/en active Active
- 2016-06-22 HU HUE16731862A patent/HUE045651T2/hu unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RU2718058C2 (ru) | 2020-03-30 |
| EP3109250A1 (en) | 2016-12-28 |
| CN107735398B (zh) | 2020-07-31 |
| SI3313853T1 (sl) | 2019-10-30 |
| EP3313853B1 (en) | 2019-05-08 |
| US10308665B2 (en) | 2019-06-04 |
| TWI646100B (zh) | 2019-01-01 |
| AR105091A1 (es) | 2017-09-06 |
| JP6745823B2 (ja) | 2020-08-26 |
| MX2017017022A (es) | 2018-08-15 |
| CN107735398A (zh) | 2018-02-23 |
| ES2741013T3 (es) | 2020-02-07 |
| TW201713669A (zh) | 2017-04-16 |
| UY36746A (es) | 2016-12-30 |
| RU2017144050A3 (pl) | 2019-11-11 |
| KR20180015257A (ko) | 2018-02-12 |
| AU2016282816A1 (en) | 2018-01-04 |
| RU2017144050A (ru) | 2019-07-23 |
| EP3313853A1 (en) | 2018-05-02 |
| KR102621941B1 (ko) | 2024-01-05 |
| JP2018518504A (ja) | 2018-07-12 |
| US20190010168A1 (en) | 2019-01-10 |
| WO2016207205A1 (en) | 2016-12-29 |
| HUE045651T2 (hu) | 2020-01-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SI3687999T1 (sl) | Derivati rapamicina | |
| SG11201706729SA (en) | Derivatives of sobetirome | |
| GB201700937D0 (en) | Synthesis method | |
| PL3313853T3 (pl) | Sposób syntezy pochodnych rapamycyny | |
| SMT202100551T1 (it) | Derivati di sobetirome | |
| IL258438B (en) | 2-Aminoquinoline derivatives as p70s6 kinase inhibitors | |
| IL248283B (en) | A method for the synthesis of cloprabine | |
| IL260070B (en) | A method for the preparation of converted 2-aryl-ethanols | |
| ZA201801650B (en) | Process for producing novel 4-benzoazonine derivatives | |
| IL271512B (en) | A method for the preparation of modified 4-aminoindan derivatives | |
| GB2564185B (en) | Process for the preparation of derivatives of benzodioxole | |
| GB201513979D0 (en) | Synthesis of benzodiazepine derivatives | |
| PT3713952T (pt) | Método para a síntese de derivados de glutationa | |
| ZA201802980B (en) | Method for the selective synthesis of trialkoxysilanes | |
| SI3221297T1 (sl) | Postopek za sintezo benzazepinskih derivatov | |
| IL266902A (en) | A method for the reduction of oxo-halogen compounds | |
| IL263091B (en) | A method for the production of heterocyclic compounds | |
| SG11201605485QA (en) | Synthesis method of 9-allylcamptothecin derivatives | |
| EP3288560A4 (en) | Methods for the synthesis of ceragenins | |
| IL253630A0 (en) | A process for the preparation of modified phenylisoxazoline derivatives | |
| PL3320102T3 (pl) | Sposób syntezy pentostatyny | |
| GB201600050D0 (en) | lmidaclothiz pharmaceutical intermediate 2-chloro-5-methylthiazole synthesis method | |
| GB201416951D0 (en) | Method of synthesis |